Literature DB >> 30335249

A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis

Leslie Alejandra Ramírez1, Elsy Arlene Pérez-Padilla, Francisco García-Oscos, Humberto Salgado, Marco Atzori, Juan Carlos Pineda.   

Abstract

The serotonergic and immunological hypothesis of depression proposes that certain types of excessive stress distort the relationship between the activities of the innate immune and central nervous systems, so that the stress caused by an infection, or excessive psychological stress, activate toll-like receptors such as the TLR-4, the transcription factor NF-kB, the inflammasome NLRP3, as well as the secretion of interleukin-1 beta (IL-1β), interleukin-6 (IL-6) and other factors of the innate immune response, causing first, the general symptoms of the disease which appear with any infection, but also those characteristic of depressive illness such as dysphoria and anhedonia. The evidence indicates that, if the stimulus persists or recurs within 24 hours, the indole-2, 3-dioxygenase enzyme (IDO) of the kynurenine metabolic pathway, which increases the synthesis of quinolinic acid, is activated with an associated reduction of serotonin synthesis. Quinolinic acid activates NMDA receptors in the central nervous system and stimulates the secretion of interleukins IL-6 and 1L-1β, among others, promoting hyper-activity of the HPA axis and reinforcing a bias of the tryptophan metabolism to produce quinolinic acid, and interleukins by the innate immune system, further reducing the synthesis of serotonin and consolidating the depressive process. We discuss the evidence showing that this process can be initiated by either interleukin stimulated by an infection or some vaccines or excessive psychological stress that activates the HPA axis together with said innate immune response, causing a process of aseptic inflammation in the central nervous system.

Entities:  

Keywords:  depresión; inmunidad innata, interleucina-1beta; interferón gamma; interleucina-10; interleucina-6; neuroglia; serotonina; sistema hipotálamohipófiso- suprarrenal; sistema inmunológico; sistema nervioso

Mesh:

Substances:

Year:  2018        PMID: 30335249     DOI: 10.7705/biomedica.v38i3.3688

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  9 in total

1.  Comorbidity of Pain and Depression in a Lumbar Disc Herniation Model: Biochemical Alterations and the Effects of Fluoxetine.

Authors:  Lun Cai; Qianchao He; Yongjing Lu; Yuying Hu; Wei Chen; Liping Wei; Yueqiang Hu
Journal:  Front Neurol       Date:  2019-09-24       Impact factor: 4.003

2.  Molecular pathology associated with altered synaptic transcriptome in the dorsolateral prefrontal cortex of depressed subjects.

Authors:  Yuta Yoshino; Bhaskar Roy; Nilesh Kumar; M Shahid Mukhtar; Yogesh Dwivedi
Journal:  Transl Psychiatry       Date:  2021-01-22       Impact factor: 6.222

Review 3.  Heart and brain interactions : Pathophysiology and management of cardio-psycho-neurological disorders.

Authors:  Renate B Schnabel; Gert Hasenfuß; Sylvia Buchmann; Kai G Kahl; Stefanie Aeschbacher; Stefan Osswald; Christiane E Angermann
Journal:  Herz       Date:  2021-02-05       Impact factor: 1.443

Review 4.  Oxytocin Signaling as a Target to Block Social Defeat-Induced Increases in Drug Abuse Reward.

Authors:  Carmen Ferrer-Pérez; Marina D Reguilón; José Miñarro; Marta Rodríguez-Arias
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

Review 5.  C-Reactive Protein as a Biomarker for Major Depressive Disorder?

Authors:  Laura Orsolini; Simone Pompili; Silvia Tempia Valenta; Virginio Salvi; Umberto Volpe
Journal:  Int J Mol Sci       Date:  2022-01-30       Impact factor: 5.923

Review 6.  Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways.

Authors:  Ana Salomé Correia; Nuno Vale
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

7.  Altered Tryptophan Metabolism on the Kynurenine Pathway in Depressive Patients with Small Intestinal Bacterial Overgrowth.

Authors:  Cezary Chojnacki; Paulina Konrad; Aleksandra Błońska; Marta Medrek-Socha; Karolina Przybylowska-Sygut; Jan Chojnacki; Tomasz Poplawski
Journal:  Nutrients       Date:  2022-08-06       Impact factor: 6.706

Review 8.  Th17-cells in depression: Implication in multiple sclerosis.

Authors:  Mikhail Melnikov; Anna Lopatina
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

Review 9.  Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature.

Authors:  Olivia Remes; João Francisco Mendes; Peter Templeton
Journal:  Brain Sci       Date:  2021-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.